Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1

Interventions

Sirolimus 7Everolimus 5ganaxolone 1dactolisib 1Vigabatrin 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Propranolol 1Aspirin 1Anticonvulsants 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Tuberous Sclerosis × Vigabatrin × Clear all
NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

University of Alabama at Birmingham

Phase 2 Completed
84 enrolled 16 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡